Occidental Petroleum Reports Strong Q1 Earnings Driven by OxyChem Divestiture and Substantial Debt Reduction
summarizeSummary
Occidental Petroleum reported robust Q1 2026 earnings, largely due to a $3.1 billion gain from the OxyChem divestiture, which enabled a substantial $7.1 billion debt reduction.
check_boxKey Events
-
Strong Q1 Financial Performance
Net income attributable to common stockholders surged to $3.175 billion ($3.13 diluted EPS) in Q1 2026, compared to $766 million ($0.77 diluted EPS) in Q1 2025, primarily driven by the OxyChem divestiture gain.
-
OxyChem Divestiture Completed
The sale of OxyChem closed on January 2, 2026, for an adjusted purchase price of $9.5 billion, resulting in a $3.1 billion net gain reported in discontinued operations.
-
Substantial Debt Reduction
The company repaid $6.7 billion of debt in Q1 2026 using OxyChem proceeds, with an additional $0.4 billion repaid subsequent to quarter-end, totaling $7.1 billion in debt reduction. Net long-term debt decreased from $20.6 billion to $15.2 billion.
-
Ongoing Share Repurchase Program
Occidental repurchased 1.38 million shares for $79 million in Q1 2026, with $1.223 billion remaining under the current authorization.
auto_awesomeAnalysis
Occidental Petroleum's Q1 2026 results reflect a significant strategic shift following the OxyChem divestiture. The substantial gain from this sale dramatically boosted net income and EPS, and critically, the proceeds were primarily used for a major debt reduction. This deleveraging significantly strengthens the company's balance sheet and aligns with its stated strategic priorities. While operating cash flow from continuing operations saw a year-over-year decrease due to working capital changes, the overall financial position improved. Investors should monitor the ongoing environmental liabilities, particularly the DASS litigation, which represents a notable long-term risk.
At the time of this filing, OXY was trading at $59.70 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $58.8B. The 52-week trading range was $38.72 to $67.45. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.